Engineering Chimeric Antigen Receptors

被引:16
作者
Kulemzin, S. V. [1 ]
Kuznetsova, V. V. [1 ]
Mamonkin, M. [3 ,4 ]
Taranin, A. V. [1 ,2 ]
Gorchakov, A. A. [1 ,2 ]
机构
[1] SB RAS, Inst Mol & Cellular Biol, Lavrentiev Ave 8-2, Novosibirsk 630090, Russia
[2] Novosibirsk State Univ, Pirogova Str 2, Novosibirsk 630090, Russia
[3] Texas Childrens Hosp, Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA
[4] Houston Methodist Hosp, Houston, TX USA
基金
俄罗斯科学基金会;
关键词
adoptive immunotherapy; cancer; chimeric antigen receptor; T cells; MODIFIED T-CELLS; SINGLE-CHAIN FV; FC-GAMMA RIIIA; ADOPTIVE IMMUNOTHERAPY; CD28; COSTIMULATION; ANTITUMOR-ACTIVITY; ENHANCED SURVIVAL; SIGNALING DOMAINS; IMMUNE RECEPTORS; REPEAT PROTEINS;
D O I
10.32607/20758251-2017-9-1-6-14
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chimeric antigen receptors (CARs) are recombinant protein molecules that redirect cytotoxic lymphocytes toward malignant and other target cells. The high feasibility of manufacturing CAR-modified lymphocytes for the therapy of cancer has spurred the development and optimization of new CAR T cells directed against a broad range of target antigens. In this review, we describe the main structural and functional elements constituting a CAR, discuss the roles of these elements in modulating the anti-tumor activity of CAR T cells, and highlight alternative approaches to CAR engineering.
引用
收藏
页码:6 / 14
页数:9
相关论文
共 103 条
[1]   Inclusion of an IgG1-Fc spacer abrogates efficacy of CD19 CAR T cells in a xenograft mouse model [J].
Almasbak, H. ;
Walseng, E. ;
Kristian, A. ;
Myhre, M. R. ;
Suso, E. M. ;
Munthe, L. A. ;
Andersen, J. T. ;
Wang, M. Y. ;
Kvalheim, G. ;
Gaudernack, G. ;
Kyte, J. A. .
GENE THERAPY, 2015, 22 (05) :391-403
[2]   CARbodies: Human Antibodies Against Cell Surface Tumor Antigens Selected From Repertoires Displayed on T Cell Chimeric Antigen Receptors [J].
Alonso-Camino, Vanesa ;
Sanchez-Martin, David ;
Compte, Marta ;
Nunez-Prado, Natalia ;
Diaz, Rosa M. ;
Vile, Richard ;
Alvarez-Vallina, Luis .
MOLECULAR THERAPY-NUCLEIC ACIDS, 2013, 2 :e93
[3]  
Altenschmidt U, 1996, CLIN CANCER RES, V2, P1001
[4]   2B4 (CD244) signaling via chimeric receptors costimulates tumor-antigen specific proliferation and in vitro expansion of human T cells [J].
Altvater, Bianca ;
Landmeier, Silke ;
Pscherer, Sibylle ;
Temme, Jaane ;
Juergens, Heribert ;
Pule, Martin ;
Rossig, Claudia .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2009, 58 (12) :1991-2001
[5]  
Annenkov AE, 1998, J IMMUNOL, V161, P6604
[6]   Chimeric NKG2D receptor-expressing T cells as an immunotherapy for multiple myeloma [J].
Barber, Amorette ;
Zhang, Tong ;
Megli, Christina J. ;
Wu, Jillian ;
Meehan, Kenneth R. ;
Sentman, Charles L. .
EXPERIMENTAL HEMATOLOGY, 2008, 36 (10) :1318-1328
[7]   Designing repeat proteins:: Well-expressed, soluble and stable proteins from combinatorial libraries of consensus ankyrin repeat proteins [J].
Binz, HK ;
Stumpp, MT ;
Forrer, P ;
Amstutz, P ;
Plückthun, A .
JOURNAL OF MOLECULAR BIOLOGY, 2003, 332 (02) :489-503
[8]   SINGLE-CHAIN ANTIGEN-BINDING PROTEINS [J].
BIRD, RE ;
HARDMAN, KD ;
JACOBSON, JW ;
JOHNSON, S ;
KAUFMAN, BM ;
LEE, SM ;
LEE, T ;
POPE, SH ;
RIORDAN, GS ;
WHITLOW, M .
SCIENCE, 1988, 242 (4877) :423-426
[9]   Genetically targeted T cells eradicate systemic acute lymphoblastic leukemia xenografts [J].
Brentjens, Renier J. ;
Santos, Elmer ;
Nikhamin, Yan ;
Yeh, Raymond ;
Matsushita, Maiko ;
La Perle, Krista ;
Quintas-Cardama, Alfonso ;
Larson, Steven M. ;
Sadelain, Michel .
CLINICAL CANCER RESEARCH, 2007, 13 (18) :5426-5435
[10]   CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia [J].
Brentjens, Renier J. ;
Davila, Marco L. ;
Riviere, Isabelle ;
Park, Jae ;
Wang, Xiuyan ;
Cowell, Lindsay G. ;
Bartido, Shirley ;
Stefanski, Jolanta ;
Taylor, Clare ;
Olszewska, Malgorzata ;
Borquez-Ojeda, Oriana ;
Qu, Jinrong ;
Wasielewska, Teresa ;
He, Qing ;
Bernal, Yvette ;
Rijo, Ivelise V. ;
Hedvat, Cyrus ;
Kobos, Rachel ;
Curran, Kevin ;
Steinherz, Peter ;
Jurcic, Joseph ;
Rosenblat, Todd ;
Maslak, Peter ;
Frattini, Mark ;
Sadelain, Michel .
SCIENCE TRANSLATIONAL MEDICINE, 2013, 5 (177)